Option Care Health, Inc. (NASDAQ:OPCH) Given Average Rating of “Moderate Buy” by Brokerages

Option Care Health, Inc. (NASDAQ:OPCH) has earned an average recommendation of “Moderate Buy” from the twelve research firms that are currently covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation, nine have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $37.5833.

Several equities research analysts recently commented on the stock. Wall Street Zen raised shares of Option Care Health from a “hold” rating to a “buy” rating in a report on Saturday, January 10th. Weiss Ratings reissued a “hold (c)” rating on shares of Option Care Health in a research note on Monday, December 29th. Barrington Research upped their price target on shares of Option Care Health from $38.00 to $42.00 and gave the stock an “outperform” rating in a research report on Friday, January 16th. TD Cowen reaffirmed a “hold” rating on shares of Option Care Health in a research note on Tuesday, January 27th. Finally, National Bank Financial set a $37.00 price objective on Option Care Health in a research note on Tuesday, January 27th.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the company. Invesco Ltd. increased its stake in shares of Option Care Health by 19.6% in the 4th quarter. Invesco Ltd. now owns 534,551 shares of the company’s stock worth $17,031,000 after acquiring an additional 87,721 shares during the last quarter. EP Wealth Advisors LLC purchased a new stake in shares of Option Care Health in the fourth quarter valued at about $225,000. Fuller & Thaler Asset Management Inc. increased its position in Option Care Health by 12.1% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 6,958,800 shares of the company’s stock worth $221,707,000 after purchasing an additional 752,058 shares during the last quarter. Freestone Grove Partners LP purchased a new position in Option Care Health during the fourth quarter worth about $29,181,000. Finally, Guggenheim Capital LLC raised its stake in Option Care Health by 81.5% during the fourth quarter. Guggenheim Capital LLC now owns 30,160 shares of the company’s stock worth $961,000 after purchasing an additional 13,541 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Stock Up 0.1%

Option Care Health stock opened at $35.69 on Friday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.56 and a quick ratio of 1.05. The stock has a market capitalization of $5.67 billion, a PE ratio of 28.33, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84. The business has a 50 day simple moving average of $33.92 and a 200-day simple moving average of $30.40. Option Care Health has a 12 month low of $24.24 and a 12 month high of $36.80.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.